Dysregulation of phospholipid metabolism of neuronal membranes in the nervous system pathology

Leskova G.F.; Kryzhanovskiĭ G.N.

doi:https://doi.org/

References:

Belokoneva O.S., Zaitsev S.V. Rol' membrannykh lipidov v regulyatsii funktsionirovaniya retseptorov neiromediatorov. Biokhimiya 1993; 58: 11: 1685-1708.
Vartanyan A.A., Aprikyan G.V., Vanyushin V.F. Metilirovanie fosfolipidov i sinapticheskii zakhvat mediatornykh aminokislot. Izv. AN SSSR. Ser biol 1990; 5: 786-789.
Leskova G.F. Rol' fosfolipidov sinapticheskikh membran v mekhanizmakh regulyatsii neirotransmissii v prodolgovatom mozge pri gemorragicheskom shoke u koshek. Patogenez 2006; 4: 3: 57-65.
Leskova G.F. Izmenenie sostava fosfolipidov sinapticheskikh membran v lobnom otdele golovnogo mozga na raznykh stadiyakh gemorragicheskogo shoka u koshek. Byul eksp biol med 2008; 381-385.
Leskova G.F., Kryzhanovskii G.N., Arkhipenko Yu.V. i dr. Sposob korrektsii gemorragicheskogo shoka. Patent na izobretenie. M 2002; 16.
Baijalich, Scheller R.H. The biochemistry of neurotransmitter secretion. J Biol Chem 1995; 270: 1971-1974.
Berman D., Dall'Armi C., Voronov S. et al. Oligomeric amyloid-β peptide disrupts phosphatudylinositol-4,5-bisphosphate metabolism. Nat Neurosci 2008; 11: 547-554.
Bi X., Liu J.,Yao Y., Lynch G. et al. Deregulation of the phosphatidylinositol-3 Kinase signaling cascade Is associated with neurodegeneration in Npc1-/- mouse brain. Am J Pathol 2005; 167: 1081-1092.
Billah M.M., Anthes J.C. The regulation and cellular functions of phosphatidylcholine hydrolisis. Biochem J 1990; 269: 281-291.
Bollag W.B., Zhong X., Dodd M.E. Phospholipase D signaling and extracellular signal-regulated kinase-1 and -2 phosphorilation (activation) are required for maximal phorbol ester-induced transglutaminase activity, a marker of keratinocyte differentiation. J Pharmacol Exp Ther 2005; 312: 1223-1231.
Borda T.G., Gremaschi G., Sterin-Borda L. Haloperidol-mediated phosphoinositide hydrolisis via activation of α1-adrenoreceptors in frontal cerebral rat cortex. Canad J Physiol Pharmacol 1999; 7: 22-28.
Castillo M.R., Babson J.R. Sa(2+)-dependent mechanisms of cell injury in cultured cortical neurons. Neuroscie 1998; 86: 1133-1144.
Sutler R.G., Kelly J., Storie K. et al. Involvenment of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimers disease. Proc Natl Acad Sci USA 2004; 101: 2070-2075.
De S.R., Agmone-Cat M.A., Nicolin A., Minghetti L. Expression of phosphatidylserine receptor and down-regulation of pro-inflammatory molecule production by its natural ligand in rat microglial cultures. J Neuropathol Exp Neurol 2000; 61: 237-244.
Farooqui A.A., Horrocks L.A., Farooqui T. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide. J Neurosci Res 2007; 85: 1834-1850.
Farooqui A.A., Ong W.Y., Horrocks L.A. Bichemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2. Neurochem. Res. 2004; 29: 1961-1977.
Gasull T., Sarri E., DeGregorio-Rocasolano N., Trullas R. NMDA receptor overaction inhibits phospholipid synthesis by decreasing choline-ethanolamine phosphotransferase activity. J. Neurosci. 2003; 23: 4100-4107.
Gatlaz W.F., Cairns N.J., Levy R. et al. Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimers disease. Eur Arch Psychiat Clin Neurosci 1996; 246: 12-131.
Griffin M.D., Mok M.L., Wilson L.M. et al. Phospholipid interaction induces molecular-level polimorphism in apoprotein C II amyloid fibrils via alternative assembly pathways. J Mol Biol 2008; 375: 240-256.
Guan Z.Z., Wang Y.N., Xiao K.Q. et al. Activity of phosphatidylethanolamine-N-methyltransferase in brain affected by Alzheimers disease. Neurochem Int 1999; 34: 41-47.
Hait N.C., Oskeritzian C.A., Paugh S.W. et al. Sphingosine kinases, sphingosine-1-phosphate, apoptosis and diseases. Biochim Biophys Acta 2006; 1758: 2016-2026.
Hashioka S., Han Y.H., Fujii S. et al. Phosphatidylserine and phosphatidylcholine- containing liposomes inhibit amiloid beta and iterferon-gamma-induced microglial activation. Free Radic Biol Med 2007; 41: 945-954.
Hirabayashi T., Murayama T., Shimizu T. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharmacol Bull 2004; 27: 1168-1173.
Horn J.-l., Janicki P.K., Sing G. et al. Reduced anestetic requirements in aged rats: association with altered brain synaptic plasma membrane Ca2+-ATPase pump and phospholipid methyltransferase I activites. Life Sci 1996; 59: PL 263-PL 268.
Kennedy B.P., Bottiglieri T., Arning E. et al. Elevated S-adenosylhomocysteine in Alzheimer brain influence on meyhyltransferases and cognitive function. J Neural Transm 2004; 111: 547-567.
Kidd P.M. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 1999; 4: 144-161.
Kingsley M. Effects of phosphatidylserine supplementation on exercising humans. Sports Med 2006; 36: 657-669.
Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 2000; 107: 1027-1063.
Likidis A., Jackowski S. Regulation of mammalian cell membrane biosynthesis. Prog Nucleic Acid Res Mol Biol 2001; 65: 361-393.
Llahi S., Fain J.N. α1-adrenergic receptor-mediated activation of phospholipase D in rat cerebral cortex. J Biol Chem 1992; 267: 3672-3685.
Martin-Pena A., Acebes A., Rodriguez J.-R. et al. Age-Independent synaptogenesis by phosphoinositide 3 kinase. J Neuroscience 2006; 26: 10199-10208.
Masgrau R., Servitja J.M., Young K.W. et al. Characterization of the metabotropic glutamate receptors mediating phospholipase C activation and calcium release in cerebellar granule cells: calcium-dependence of the phospholipase C response. Eur J Neurosci 2001; 13: 248-256.
McDaniel M.A. Maier S.F., Einstein G.O. Brain-specific nutrients: a memory cure? Nutration 2003; 19: 957-975.
Milstein S., Gude D., Spiegel S. Sphingosine-1-phosphate in neural signalling and function. Acta Pediat Suppl 2007; 96: 40-43.
Min D.S., Park S.K., Exton J.H. Characterization of a rat brain phospholipase D isozyme. J Biol Chem 1998; 273: 7044-7051.
Mohmmad A. H., Butterfild D.A. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D 609) and ferulic acid ethyl ester: implications for Alzheimers disease. Biochim Biophys Acta 2005; 140-148.
Morgan C.P., Skippen A., Sequi B. et al. Phosphorilation of a distinct structural form of phosphatidylinositol transfer protein α at Ser166 by protein kinase C disrupt receptor-mediated phospholipase C signaling by inhibiting delivery of phosphatidylinositol to membranes. J Biol Chem 2004; 279: 47159-47171.
Mozzi R., Buratta S., Goracci G. Metabolism and functions of phosphatidylserine in mammalian brain. Neurochem Res 2003; 28: 195-214.
Nacane M., Kubota M., Nakagomi T. et al. Lethal forebrain ischemia stimulates sphingomyelin hidrolisis and ceramide generation in the gerbil hippocampus. Neurosci Letters 2000; 296: 89-92.
Ohanian J., Ohanian V. Spingolipids in mammalian cell signalling. Cell Mol Life Sci 2001; 58: 2053-2068.
Oskeritzian C.A., Milstien S., Spigel S. Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis. Pharm Ther 2007; 115: 390-399.
Persard S., Panagia V. Abnormal synthesis of N-methylated phospholipids during calcium paradox of the heart. J Mol Cell Cardiol 1995; 27: 579-587.
Pyne S., Pyne N.J. Sphingosine-1-phosphate signaling in mammalian cells. Biochem J 2000; 340: 385-402.
Ross B.M., Moszczynska A., Erlich J., Kish S.J. Phospholipid-metabolizing enzymes in Alzheimers disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. J Neurochem 1998; 70: 786-793.
Ruvolo P.P. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia 2001; 15: 1153-1160.
Schaeffer E.L., Gatlaz W.F. Inhibition of calcium-independent phosohilipase A2 activity in rat hippocampus acquisition of short- and long term memory. Psychopharmacology (Berl) 2005; 181: 392-400.
Schaeffer E.L., Gatlaz W.F. Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimers disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berl) 2008; 198: 1-27.
Secades J.J., Lorenzo J.L. Citicoline: pharmacological and clinical review. Methods Find Exp Clin Pharmacol 2006; 28: Suppl B: 1-56.
Sieber F.E., Traustman R.J., Martin L.J. Delayed neuronal death after global incomplete ischemia in dogs is accompanied by changes in phospholipase C protein expression. J Cerebral Blood Flow and Metabolism 1997; 17: 527-533.
Singh I.N., Hall E.D. Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury. J Neurosci Res 2008; 86: 1419-1433.
Spigel S., Kolesnick R. Sphingosine-1-phosphate as therapeutic agent. Leukemia 2002; 16: 1596-1602.
Sun G.Y., Xu J., Jensen M.D., Simonyi A. Phospholipase A2 in the central nervous system: implication for neurodegenerative diseases. J Lipid Res 2004; 45: 205-213.
Tranberg M., Stridh M.H., Guy Y. et al. NMDA-receptor mediated efflux of N-acetylaspartate: physiological and/or pathological importance? Neurochem Int 2004; 45: 1195-1204.
Wallace M.A. Effects of Alzheimers disease-related β amiloid protein fragments on enzymes metabolising phosphoinositides in brain. Biochim Biophys Acta 1994; 1227: 163-167.
Wu B., Khagawa K., Yagyu K. et al. Phosphatidylinositol and PI-monophosphate recover amyloid beta protein-induced inhibition of CL–-ATPase activity. Life Sci 2002; 72: 455-463.
Zembrzcka A., Kacprzak M. Apolipoprotein E4 and A beta peptide 1-42 inhibit polyphosphoinositide biosynthesis in rat brain cortex. Pol J Pharmacol 2003; 55: 911-913.
Zeng C., Lee J.T., Chen H. et al. Amyloid-beta peptide enhances tumor necrosis factor -alpha-induced NOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes. J Neurochem 2005; 94: 702-712.
Zenser E.G., Hartman T., Grimm M.O.W. Amyloid beta-protein and lipid metabolism. Biochim Biophys Acta 2007; 1768: 1991-2001.
Zieminska E., Lazarewicz J.W. Extotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol Exper 2006; 66: 301-309.